Multispectral Confocal 3D Imaging of Intact Healthy and Tumor Tissue Using MLSR-3D
Overview
Authors
Affiliations
Revealing the 3D composition of intact tissue specimens is essential for understanding cell and organ biology in health and disease. State-of-the-art 3D microscopy techniques aim to capture tissue volumes on an ever-increasing scale, while also retaining sufficient resolution for single-cell analysis. Furthermore, spatial profiling through multi-marker imaging is fast developing, providing more context and better distinction between cell types. Following these lines of technological advance, we here present a protocol based on FUnGI (fructose, urea and glycerol clearing solution for imaging) optical clearing of tissue before multispectral large-scale single-cell resolution 3D (mLSR-3D) imaging, which implements 'on-the-fly' linear unmixing of up to eight fluorophores during a single acquisition. Our protocol removes the need for repetitive illumination, thereby allowing larger volumes to be scanned with better image quality in less time, also reducing photo-bleaching and file size. To aid in the design of multiplex antibody panels, we provide a fast and manageable intensity equalization assay with automated analysis to design a combination of markers with balanced intensities suitable for mLSR-3D. We demonstrate effective mLSR-3D imaging of various tissues, including patient-derived organoids and xenografted tumors, and, furthermore, describe an optimized workflow for mLSR-3D imaging of formalin-fixed paraffin-embedded samples. Finally, we provide essential steps for 3D image data processing, including shading correction that does not require pre-acquired shading references and 3D inhomogeneity correction to correct fluorescence artefacts often afflicting 3D datasets. Together, this provides a one-week protocol for eight-fluorescent-marker 3D visualization and exploration of intact tissue of various origins at single-cell resolution.
Human breast tissue engineering in health and disease.
Buchholz M, Scheerman D, Levato R, Wehrens E, Rios A EMBO Mol Med. 2024; 16(10):2299-2321.
PMID: 39179741 PMC: 11473723. DOI: 10.1038/s44321-024-00112-3.
Alieva M, Barrera Roman M, de Blank S, Petcu D, Zeeman A, Dautzenberg N Nat Protoc. 2024; 19(7):2052-2084.
PMID: 38504137 DOI: 10.1038/s41596-024-00972-6.
Blueprints from plane to space: outlook of next-generation three-dimensional histopathology.
Yoshikawa A, Omura T, Takahashi-Kanemitsu A, Susaki E Cancer Sci. 2024; 115(4):1029-1038.
PMID: 38316137 PMC: 11006986. DOI: 10.1111/cas.16095.
Pagliaro A, Finger R, Zoutendijk I, Bunschuh S, Clevers H, Hendriks D Nat Commun. 2023; 14(1):7361.
PMID: 38016960 PMC: 10684874. DOI: 10.1038/s41467-023-43141-1.
New Challenges for Anatomists in the Era of Omics.
Stabile A, Pistilli A, Mariangela R, Rende M, Bartolini D, Di Sante G Diagnostics (Basel). 2023; 13(18).
PMID: 37761332 PMC: 10529314. DOI: 10.3390/diagnostics13182963.